Probiotics: A Review of Human Studies to Date and Methodological Approaches

References

• Metchnikoff E. The prolongation of life. 1" ed. New York: Putnam Sons, 1908.
   Google Scholar
• Metchnikoff E. The Nature of Man. Studies in Optimistic Philosophy. William Heinemann, 1908.
   Google Scholar
• Rettger LF, Chaplin HA. Treatise on the transformation of the intestinal flora with special reference to the implantation of Bacillus acidophilus. New Haven, Connecticut: Yale Uni-versity Press, 1921.
   Google Scholar
• Syed SA, Abrams GD, Freter R. Efficiency of various intestinal bacteria in assuming normal functions of enteric flora after association with germ free mice. Infect Immun 1970; 2: 376–86.
   Google Scholar
• Schwan A, Sjolin S, Trottestam U, Aronsson B. Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis 1984; 16: 211–5.
   PubMed Web of Science ®Google Scholar
• Fuller R Probiotics in human medicine. Gut 1991; 32: 439–42.
   Web of Science ®Google Scholar
• Gorbach SL. Function of the normal human microflora. Scand J Infect Dis 1986; supp 49: 17–30.
   Google Scholar
• Bernet MF, Brassart D, Neeser R, Servin AL. Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enteroviru-lent bacteria. Gut 1994; 35: 483–9.
   PubMed Web of Science ®Google Scholar
• Gibson GR, Beatty EH, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofruc-tose and inulin. Gastroenterology 1995; 106: 975–82.
   Google Scholar
• Scheinbach S. Probiotics: functionality and commercial status. Biotechnol Adv 1998; 16: 581–608.
   PubMed Web of Science ®Google Scholar
• Guideline for good clinical pratice. Step 4 1996; 01 May.
   Google Scholar
• Eschwège E, Bouvenot G. Essais explicatifs ou pragmatiques: le dualisme. Rev Méd Interne 1994; 15: 357–61.
   Web of Science ®Google Scholar
• Diplock A, Aggett P, Ashwell M, Bomet F, Fern E, Rober-froid M. Scientific concepts of functional foods in Europe: Consensus document. Br J Nutr 1999;81 Suppl 1.
   Google Scholar
• De Roos N, Katan M. Effects of probiotic bacteria on diarrhoea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr 2000; 71: 405–11.
   PubMed Web of Science ®Google Scholar
• Meydani S, Ha WK. Immunologic effects of yoghurt. Am J Clin Nutr 2000; 71: 861–72.
   PubMed Web of Science ®Google Scholar
• Roberfroid M. In Ingredients. Health Nutr 1998; 4: 3–4.
   Google Scholar
• Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus Strain (Lactobacillus casei sp GG) promotes recovery from acute diarrhoea in children. Pedi-atrics 1991; 88: 90–7.
   Google Scholar
• Isolauri E, aila M, Mykkanen H, Ling WH, Salminen S. Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci 1994; 39: 2595–600.
   PubMed Web of Science ®Google Scholar
• Saavadra JM, Bauman NA, Oung I, Peman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus ther-mophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994; 344: 1046–9.
   Google Scholar
• Bellomo G, Mangiagle A, Nicastro L, Frigerio G. A con-trolled double-blind study of SF68 strain as a new biological preparation for the treatment of diarrhoea in paediatrics. Curr Ther Res 1980; 28: 927–36.
   Web of Science ®Google Scholar
• Chapoy P. Traitement des diarrhees aigues infantiles: Essai control& de Saccharomyces boulardii. Ann Pediatr 1985; 32: 561–3.
   Google Scholar
• Oberhelman R, Gilman RH, Sheen P, Taylor D, Black R, Cabrera L, Lescano A, Mesa R, Madico G. A placebo controlled trial of Lactobacillus GG to prevent diarrhoea in undernourished Peruvian children. J Paediatr 1999; 134: 15–20.
   Google Scholar
• Pedone C, Bemabeu A, Postaire E, Bouley A, Reinert P. The effect of supplementation with milk fermented by Lactobacil-lus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int J Clin Pract 1999; 53: 179–84.
   Google Scholar
• Chicoine L, Joncas JH. Emploi des ferments lactiques dans la gastro-enterite non bactérienne. Union Med Can 1973; 102: 1114–5.
   Google Scholar
• Pearce JL, Hamilton JR. Controlled trial of orally adminis-tered lactobacilli in acute infantile diarrhoea. J Pediatr 1974; 84: 261–2.
   PubMed Web of Science ®Google Scholar
• Tojo M, Oikawa T, Morikawa Y, et al. The effects of Bifidobacterium breve administration on campylobacter en-teritis. Acta Paediatr Japan 1987; 29: 160–7.
   Google Scholar
• Clements ML, Levine MM, Black RE, et al. Lactobacillus prophylaxis for diarrhoea due to enterotoxigenic Escherichia coli. Antimicorb Agents Chemother 1981; 20: 104–8.
   Google Scholar
• Mitra AK, Rabbani GB. A double-blind, controlled trial of Bioflorin (Streptococcus faecium SF68) in adults with acute diarrhoea due to Vibrio cholerae and enterotoxigenic cherichia coli. Gastroenterology 1990; 99: 1149–52.
   PubMed Web of Science ®Google Scholar
• Camarri E, Belvisi A, Guidoni G, Marini G, Frigerio G. A double-blind comparison of two different treatments for acute enteritis in adults. Chemotherapy 1981; 27: 466–70.
   Google Scholar
• Wunderlich PF, Braun L, Fumagalli I, et al. Double-blind report on the efficacy of lactic acid producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea in the treatment of acute diarrhoea. J Int Med Res 1989; 17: 333–8.
   PubMed Web of Science ®Google Scholar
• Saint-Marc T, Rossello-Prats L, Touraine JL. Efficacité de Saccharomyces boulardii dans le traitement des diarrhées du SIDA. Ann Méd Interne 1991; 142: 64–5.
   PubMedGoogle Scholar
• Black FT, Andersen PL, Orskov J, Orskov F, Gaarslev K, Laulund S. Prophylactic efficacy of lactobacilli on travellers diarrhoea. In: Steffen R, ed. Travel medicine. Conference on international travel medicine 1, Zurich, Switzerland. Berlin: Springer, 1989: 333–5.
   Google Scholar
• Oksanen PJ, Salminen S, Saxelin M, et al. Prevention of traveller's diarrhoea by Lactobacillus GG. Ann Med 1990; 22: 53–6.
   PubMed Web of Science ®Google Scholar
• Kollaritsch H, Holst H, Grobara P, Wiedermann G. Prophy-laxe der Reisediarrhee mit Saccharomyces boulardii. Fortschr Med 1993; 111: 153–6.
   Google Scholar
• Pozo-Olano JD, Warram JH, Gomez RG, Cavazos MG. Effect of a Lactobacilli preparation on traveller's diarrhoea. Gastroenterology 1978; 74: 829–30.
   Google Scholar
• Katelaris PH, Salam I. Lactobacilli to prevent traveller's diarrhoea? N Eng J Med 1995; 7: 333–5.
   Google Scholar
• Bartlett JG. Antibiotic-associated diarrhoea. Clin Infect Dis 1992; 23: 573–81.
   Google Scholar
• McFarland LV. Diarrhoea acquired in the hospital. In: Gianella RA, ed. Acute Infectious Diarrhoea. Philadelphia, PA: WB Saunders Co, 1993: 563–77.
   Google Scholar
• Zaidi N, Ponce de Leon S, Ortiz RM, et al. Hospital-acquired diarrhoea in adults: a prospective case controlled study in Mexico. Infect Control Hosp Epidemiol 1991; 12: 349–55.
   PubMed Web of Science ®Google Scholar
• Adam J, Barret A, Barret-Bellet C. Essais cliniques contrôlés en double insu de l'ultra-levure lyophilisée. Etude multi-cen-trique par 25 médecins de 388 cas. Gaz Med Francaise 1977; 84: 2072–8.
   Google Scholar
• Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G. Prevention of antibiotic-associated diarrhoea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96: 981–8.
   Google Scholar
• McFarland LV, Surawicz CM, Greenberg RN, et al. Preven-tion of beta lactam associated diarrhoea by Saccharomyces boulardii compared to placebo. Am J Gastroentero11995; 90: 439–48.
   PubMed Web of Science ®Google Scholar
• Gotz V, Romankiewicz JA, Moss J, Murray HVV. Prophylaxis against ampicillin-associated diarrhoea with a Lactobacillus preparation. Am J Hosp Pharm 1979; 36: 754–7.
   PubMedGoogle Scholar
• Tankanow RM, Ross MB, Ertel IJ, Dickinson DG, Mc-Cormick LS, Garfinkel JF. A double-blind, placebo-con-trolled study of the efficacy of Lactinex in the prophylaxis of amoxycillin-induced diarrhoea. DICP 1990; 24: 382–4.
   Google Scholar
• Siitonen S, Vapaatalo H, Salminen S, et al. Effect of Lacto-bacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med 1990; 22: 57–9.
   PubMed Web of Science ®Google Scholar
• Colombel JF, Cortot A, Neut C, Romond C. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gas-trointestinal effects. Lancet 1987; 2: 43.
   PubMed Web of Science ®Google Scholar
• Orrhage, Brismar B, Nord CE. Effects of supplements of Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin. Microb Ecol Health Dis 1994; 7: 17–25.
   Google Scholar
• Wunderlich PF, Braun L, Fumagalli I, et al. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res 1989; 17: 333–8.
   PubMed Web of Science ®Google Scholar
• Chabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalised pa-tients: evidence for colonised new admissions as a source of infection. J Infect Dis 1992; 166: 561–7.
   Google Scholar
• McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320: 204–10.
   PubMed Web of Science ®Google Scholar
• Fekety R, McFarland LV, Surawicz CM, Green burg RN, Elmer GW, Mulligan ME. Recurrent Clostridium difficile diarrhoea: Characteristics of and risk factors for patients enrolled in a prospective, randomised, double blinded trial. Clin Inf Dis 1997; 24: 324–33.
   Google Scholar
• Olson MM, Shanholtzer CJ, Lee JT, Gerding DN. Ten years of prospective Clostridium difficile-associated disease surveil-lance and treatment at the Minneapolis VA medical center. 1982-1991. Infect Contr Hosp Epidemiol 1994; 15: 371–81.
   Google Scholar
• Bender BS, Laughon BE, Gaydos C. Is Clostridium difficile endemic in chronic-care facilities? Lancet 1986; II: 11–3.
   Google Scholar
• Walters BAJ, Roberts R, Stafford R, Seneviratne E. Recur-rence of antibiotic associated colitis: endogenous persistence of C. difficile during vancomycin therapy. Gut 1983; 24: 206–12.
   Google Scholar
• O'Neill GL, Beaman MH, Riley TV. Relapse versus reinfec-tion with Clostridium difficile. Epidemiol Infect 1991; 107: 627–35.
   PubMed Web of Science ®Google Scholar
• Johnson S, Adelmann A, Clabots CR, Peterson LR, Gerding DN. Recurrences of Clostridium difficile diarrhoea not caused by the original infecting organism. J Infect Dis 1989; 159: 340–3.
   Google Scholar
• Bowden TA, Mansberger AR, Lykins LE. Pseudomembra-nous enterocolitis: mechanism of restoring floral homeosta-sis. Ann Surg 1982; 4: 178–83.
   Google Scholar
• Tvede M, Rask-Madsen J. Bacteriotherapy for chronic re-lapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; 1: 1156–60.
   PubMed Web of Science ®Google Scholar
• Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987; 2: 1519.
   Google Scholar
• Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL. Treatment of recurrent Clostridium difficile colitis with Lac-tobacillus GG. J Pediatr Gastroenterol Nutr 1995; 21: 224–6.
   PubMed Web of Science ®Google Scholar
• Surawiscz CM, McFarland LV, Elmer GW, Chinn J. Treat-ment of recurrent Clostridium difficile colitis with van-comycin and Saccharomyces boulardii. Am J Gastroenterol 1989; 84: 1285–7.
   Web of Science ®Google Scholar
• McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces bou-lardii in combination with standard antibiotics for Clostrid-ium difficile disease. JAMA 1994; 271: 1913–8.
   PubMed Web of Science ®Google Scholar
• Buts JP, Corthier G, Delmée M. Saccharomyces boulardii for Clostridium difficile associated enteropathies in infants. J Pediatr Gastroenterol Nutr 1993; 16: 419–25.
   PubMed Web of Science ®Google Scholar
• Seal D, Bothell° SP, Barclay F, Welch A, Piper M, Bonny-castle M. Treatment of relapsing Clostridium difficile di-arrhoea by administration of a non-toxigenic strain. Eur J Clin Microbiol 1987; 6: 51–3.
   PubMedGoogle Scholar
• Schellenberg D, Bonington A, Champion CM, Lancaster R, Webb S, Main J. Treatment of Clostridium difficile diarrhoea with brewer's yeast. Lancet 1994; 343: 171–2.
   PubMed Web of Science ®Google Scholar
• Belitsos PC, Greenson JK, Tardley JH, Sisler JR, Bartlett JG. Association of gastric hypoacidity with opportunistic infections in patients with AIDS. J Infect Dis 1992; 166: 277–84.
   Google Scholar
• Saint-Marc T, Rossello-Prats L, Touraine JL. Efficacité de Saccharomyces boulardii dans le traitement des diarrhees du SIDA. Ann Med Interne (Paris) 1991; 142: 64–5.
   PubMedGoogle Scholar
• Graf W. Studies on the therapeutic properties of acidophilus milk. In: Hallgren Bo, ed. Nutirtion and Intestinal Flora. Stockholm: Symposia of the Swedish Nutrition Foundation XV. Almqvist & Wiksell International, 1983: 119–21.
   Google Scholar
• Alm L, Humble D, Ryd-Kjellen E, Setterberg G. The effect of acidophilus milk in the treatment of constipation in hospitalised geriatric patients. In: Hallgren B, ed. Nutrition and Intestinal Flora. Stockholm: Symposia of the Swedish Nutrition Foundation XV. Almqvist & Wiksell Interna-tional, 1983: 131–8.
   Google Scholar
• Ling WH, Hänninen 0, Mykkänen H, Heikura M, Salminen S, Von Wright A. Colonization and faecal enzyme activities after oral Lactobacillus GG administration in elderly nursing home residents. Ann Nutr Metab 1992; 36: 162–6.
   Google Scholar
• Benno Y, He F, Hosoda M, Hashimoto H, Kojima T, Yamazaki K, lino H, Mykkänen H, Salminen S. Effects of Lactobacillus GG yoghurt on human intestinal microecology in Japanese subjects. Nutrition Today Supplement 1996; 31: 9S–11S.
   Google Scholar
• Ogawa T, Hirai R, Nakakuni H, Sato Y, Wakisaka S, Tachibana M, Tominaga H, Kurata M, Matsubayashi K. Clinical experience with the use of the high concentration lactic acid bacteria preparation LP-201 to treat habitual constipation. Clin Rep 1974; 8: 1085–92.
   Google Scholar
• Seki M, Igarashi M, Fukuda Y, Simamura S, Kawashima Y, Ogasa K. The effect of bifidobacterium cultured milk on the 'regularity' among aged group. J Jap Soc Food Science Technology 1978; 4: 379–87.
   Google Scholar
• Tanaka R, Shimosaka K. Investigation of the stool fre-quency in elderly who are bed ridden and its improvements by ingestion of bifidus yoghurt. Nippon Ronen Igakkai Zasshi 1982; 19: 557–82.
   Google Scholar
• Takiguchi R, Miyamoto M, Mochizuki E, Suzuki Y, Kageyyama R, lino H. Effects of fermented-milk adminis-tration on defecation and faecal microflora of healthy volun-teers. Jap J Nutrition 1998; 11: 117–22.
   Google Scholar
• Grimaud JC, Bouvier JG, Bertolino JG, Salducci J, Chiarelli P, Bouley C. Effets du lait ferment& contenant du Bifidobac-terium sur le temps de transit colique. Gastroenterol Clin Biol 1993;17:A 127 (abstract)
   Google Scholar
• Grimaud JC, Bouvier JG, Marteau P, Bommelaer G, Sal-ducci J, Chiarelli P, Bouley C. Effect of Bifidobacterium fermented milk (Bio Strain) on the colonic transit time in healthy humans. In Les bactéries lactiques, Actes du Collo-que Lactique 94, 7–9 Sept. 1994, Caen, France: Presses universitaires de Caen, 406 (Abstract of poster)
   Google Scholar
• Mance S, Turchet P, Raimondi A, Antoine JM, Cayuéla C, Postaire E, Lucas C. Effect of a milk fermented by Bifidobacterium SP. DN-173010 (BIOTM) on the oro-fecal transit time in elderly. Gut 1999; 45 (Suppl 5): A327.
   Google Scholar
• Rajala S, Salminen S, Seppänen J, Vapaatalo H. Treatment of chronic constipation with lactitol sweetened yoghurt sup-plemented with guar gum and wheat bran in elderly hospital in-patients. Compr Gerontol A 1988; 2: 83–6.
   Google Scholar
• Bartram HP, Scheppach W, Gerlach S, Ruckdeschel G, Kelber E, Kasper H. Does yoghurt enriched with Bifidobac-terium longum affect colonic microbiology and faecal metabo-lites in healthy subjects? Am J Clin Nutr 1994; 59: 428–32.
   Google Scholar
• Tomoda T, Nakano Y, Kageyama T. Effect of yoghurt and yoghurt supplemented with Bifidobacterium and/or lactulose in healthy persons: a comparative study. Bifidobacteria Mi-croflora 1991; 10: 123–30.
   Google Scholar
• Larsen B. Vaginal flora in health and disease. Clin Obstet Gynecol 1993; 36: 107–21.
   PubMed Web of Science ®Google Scholar
• Reid G, Bruce AW, McGroarty JA, Cheng KJ, Costerton JVV. Is there a role for Lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev 1990; 3: 335–44.
   Google Scholar
• Hillier SL, Krohn MA, Rabe LK, Klebanoff SJ, Eschenbach DA. The normal vaginal flora, H202 producing lactobacilli and bacterial vaginosis in pregnant women. Clin Infect Dis 1993; 16 (Suppl 4): S273–81.
   Google Scholar
• Hilton E, Isenberg HD, Alperstein P, France K, Borenstein MT. Ingestion of yoghurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992; 116: 353–7.
   Google Scholar
• Hilton E, Rindos P, Isenberg HD. Lactobacillus GG vaginal suppositories and vaginitis. J Clin Microbiol 1995; 33: 1433.
   Google Scholar
• Reid G, Bruce AW, Taylor M. Influence of three day antimicrobial therapy and Lactobacillus vaginal suppsitories on recurrence of urinary tract infections. Clin Ther 1992; 14: 11016.
   Google Scholar
• Lin M, Savaiano D, Harlander S. Influence of nonfermented dairy products containing bacterial starter cultures on lactose maldigestion in humans. J Dairy Sci 1991; 74: 87–95.
   Google Scholar
• Savaiano DA, El Anouar Abou, Smith A, Levitt DE. Lactose malabsorption from yoghurt, pasteurized yoghurt, sweet acidophilus milk, and cultured milk in lactase deficient indi-viduals. Am J Clin Nutr 1984; 40: 1219–23.
   PubMed Web of Science ®Google Scholar
• Lebours E, Berrada N, Colin R Disponibilitê du lactose ingéré sous differentes formes de produits laitiers fermentés. In: Syndifrais A, ed. Fermented Milks Current Research. Paris: John Libbey, Eurotext, 1989: 223–8.
   Google Scholar
• Gilliland SE. Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol Rev 1990; 87: 175–88.
   Web of Science ®Google Scholar
• Gilliland SE, Nelson CR, Maxwell C. Assimilation of choles-terol by Lactobacillus acidophilus 1985; 49: 377–81.
   Google Scholar
• Danielson AD, Peo ER, Shahani KM, Lewis Al, Whalen PJ, Amer MA. Anticholetrolemic property of Lactobacillus acidophilus yoghurt fed to mature boars. J Animal Sci 1989; 67: 966–74.
   PubMed Web of Science ®Google Scholar
• Hepner G, Fried R, StJeor S, Fusetti L, Morin R. Hypoc-holesterolemic effect of yoghurt and milk. An J Clin Nutr 1979; 32: 19–24.
   PubMed Web of Science ®Google Scholar
• Mann GV, Spoerry A. Studies of a surfactant and choles-terolemia in the Massai. Am J Clin Nutr 1974; 27: 464–9.
   PubMed Web of Science ®Google Scholar
• Roussouw JE, Burger E, Van der Vyer P, Ferreira JJ. The effect of skim milk, yoghurt and full cream milk on human serum lipids. Am J Clin Nutr 1981; 34: 351–6.
   Google Scholar
• Thompson LU, Jenkins DJA, Amer V, Reichert R, Jenkins A, Kamulsky J. The effect of fermented and unfermented milks on serum cholesterol. Am J Clin Nutr 1982; 36: 1106–11.
   PubMed Web of Science ®Google Scholar
• Lin SY, Ayres JVV, Winker Jr W, Sandine WE. Lactobacillus effects on cholesterol in vitro and in vivo results. J Dairy Sci 1989; 72: 2885–9.
   PubMed Web of Science ®Google Scholar
• Rowland I. In: Human Colonic Bacteria; Role in Nutrition, Physiology and Pathology. 1995; CRC Press. Pp 155–174.
   Google Scholar
• Morotomi M. Properties of Lactobacillus caseii shirota strain as probiotics. Asia Pacific J Clin Nutr 1996; 5: 29–30.
   Google Scholar
• Boutron M-C, Faivre J, Marteau P, Couillault C, Senesse P, Quipourt V. Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: A French case-control study. Br J Cancer 1996; 74: 145–51.
   Google Scholar
• Aso Y, Akazan H. Prophylactic effect of Lactobacillus casei preparation on the recurrence of superficial bladder cancer. Urol Int 1992; 49: 125–9.
   PubMed Web of Science ®Google Scholar
• Aso Y, Akazan H, Kotake T, Tsukamoto T, Imai K, Naito S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double blind trial. Eur J Urol 1995; 27: 104–9.
   PubMed Web of Science ®Google Scholar
• Macbeth WAAG, Kass EH, McDermott WV. Treatment of hepatic encephalopathy by alteration of intestinal flora with Lactobacillus acidophilus. Lancet 1965; I: 399–403.
   Google Scholar
• Loguercio C, Abbiati R, Rinaldi M, Romano A, Blanco CDV, Coltorti M. Longterm effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy. J Hepatol 1995; 23: 39–46.
   PubMed Web of Science ®Google Scholar
• Read AE, McCarthy CF, Heaton KW, Laidlaw J. Lacto-bacillus acidophilus in treatment of hepatic encephalopathy. Br Med J 1966; I: 1267–9.
   Google Scholar
• Midolo PD, Lambert JR, Luo F, Grayson ML. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J Appl l3acteriol 1995; 79: 475–9.
   PubMedGoogle Scholar
• Campieri M, Gionchetti P. Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? Gastroenterology 1999; 116: 1246–60.
   PubMed Web of Science ®Google Scholar
• Fabia R, Ar'Rajab A, Johansson M-L, Willen R, Andersson R, Molin G, Bengmark S. The effect of exogenous adminis-tration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat. Scand J Gastroenterol 1993; 28: 155–62.
   Google Scholar
• Schultz M, Veltkamp C, Dieleman LA, Wyrick PB, Tonkon-ogy SL, Sartor RB. Continuous feeding of Lactobacillus plantarurn attenuates established colitis in interleukin-10 defi-cient mice. Gastroenterology 1998; 114: A1081.
   Google Scholar
• Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolle M. Double-blind comparison of an oral Ercherichia coli prepara-tion and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 1997; 11: 853–8.
   PubMed Web of Science ®Google Scholar
• Venturi A, Gionchetti P, Rizzello F, Peruzzo S, Zucconi E, Brigidi P, Matteuzzi K, Campieri M. Impact on the faecal flora composition of a new probiotic preparation. Preliminary data on maintenance treatment of patients with ulcerative colitis intolerant or allergic to 5-aminosalicylic acid. Aliment Pharmacol Ther 1999 (in press).
   Google Scholar
• Gionchetti P, Rizzello F, Venturi A, Matteuzzi D, Rossi M, Peruzzo S, Poggioli G, Bazzocchi G, Campieri M. Mainte-nance treatment of chronic pouchitis: a randomized, placebo controlled, double-blind trial with a new probiotic prepara-tion (abstr). Gastroenterology 1998;114.
   Google Scholar
• Plein K, Hotz J. Therapeutic effects of Saccharomyces bou-lardii on mild residual symptoms in a stable phase of Crohn's disease with special respect to chronic diarrhoea-a pilot study. S Gastroenterol 1993; 31: 129–34.
   Google Scholar
• Rembacken l 3J, Snelling AM, Hawkey PM, Axon ATR A double-blind trial of non-pathogenic E. coli vs mesalazine for the treatment of ulcerative colitis. Gut 1997; 41: A70.
   Google Scholar
• Temple JK, Steidel Al, Blehaut H, Hasselmann M, Lutun P, Maurier F. Prevention par Saccharomyces boulardii des di-arhées de l'alimentation enterale a debit confirm. Sem Hop Paris 1983; 59: 1409–12.
   Google Scholar
• Attar A, Bouhnik Y, Flourie B. Efficacy of two antibiotics and a probiotic in the treatment of small intestinal bacterial overgrowth. Gut 1996; 39: A173.
   Google Scholar
• Bazzoli E, Zagari RM, Fossi S, et al. In vitro Helicobacter pylori clearance failure with Lactobacillus acidophilus. Gas-troenterology 1992; 102: A38.
   Google Scholar
• Salminen E, Elomaa I, Minkkinen J, Vapaatalo H, Salminen S. Preservation of intestinal integrity during radiotherpay using live Lactobacillus acidophilus cultures. Clin Radio11988; 39: 435–7.
   Google Scholar
• Young RJ, Vanderhoof JA. Probiotic therapy in children with short bowel syndrome and bacterial overgrowth. Gastroen-terology 1997; 112: A916.
   Web of Science ®Google Scholar
• O'Sullivan M, O'Morain C. Probiotics in the treatment of irritable bowel syndrome (IBS)-a randomised double blind placebo controlled crossover study. Gastroenterology 1996; 110: A385.
   Web of Science ®Google Scholar
• Hentschel C, Bauer J, Dill N. Complementary medicine in non-ulcer dyspepsia: is alternative medicine a real alternative? A randomised placebo controlled double blind clinical trail with two probiotic agents. Gastroenterology 1997; 112: A146.
   Google Scholar
• Gasser F. Safety of lactic acid bacteria and their occurrence in human clinical infections. Bulletin Institut Pasteur 1994; 92: 45–67.
   Google Scholar
• Aguirre M, Collins MD. Lactic acid bacteria and human clinical infection. J Appl Bacteriol 1993; 75: 95–107.
   PubMedGoogle Scholar
• Saxelin M, Chuang NH, Chassy B, Rautelin H, Makela PH, Salminen S, Gorbalch SL. Lactobacilli and bacteremia in Southern Finland 1996; 22: 564–6.
   Google Scholar
• Saxelin M, Rautelin H, Salminen S, Makela P. The safety of commercial products with viable Lactobacillus strains. Infect Dis Clin Pract 1996; 5: 331–5.
   Web of Science ®Google Scholar
• Mynott TL, Chandler DS, Luke RK. Efficacy of enteric-coated protease in preventing attachment of enterotoxigenic Escherichia coli and diarrhoeal disease in the RITARD model. Infect Immun 1991; 59: 3708–9.
   Google Scholar
• Harty DWS, Oakey JH, Patrikakis M, Hume EBH, Knox KW. Pathogenic potential of lactobacilli. Int J Food Micro-biol 1994; 24: 179–89.
   PubMed Web of Science ®Google Scholar
• Eng RHK, Drehmel R, Smith SM, Goldstein EJC. Saccha-romyces cerevisiae infection in man. Sabouradia 1984; 22: 40–7.
   Google Scholar
• Aucott JN, Fayen J, Grossnicklas H, Morrissey A, Lederman MM, Salata RA. Invasive infection with Saccharomyces cerevisiae: report of three cases and review. Rev Infect Dis 1990; 12: 406–11.
   PubMedGoogle Scholar
• Bonnay S, Darchis JP, Veyssier P. Saccharomyces cerevisiae septicaemia in a cancer patient Med Malad Infect 1991; 21: 73.
   Google Scholar
• Doyle MG, Pickering LK, O'Brian N, Hoots K. Saccha-romyces cerevisiae infection in a patient with acquired im-munodeficiency syndrome. Pediatr Infect Dis J 1990; 9: 850–1.
   Google Scholar
• Pletinex M, Legein J, Vandenplas Y. Fungaemia with Saccha-romyces boulardii in a 1 year old girl with protracted di-arrhoea. J Pediatr Gastroenterol Nutr 1995; 21: 113–5.
   Google Scholar
• McConnell MA, Mercer AA, Tannock GW. Transfer of plasmid pAMbetal between members of the normal mi-croflora inhabiting the murine digestive tract and modifica-tion of the plasmid in a Lactobacillus reuteri host. Microb Ecol Health Dis 1991; 4: 343–55.
   Google Scholar
• Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut 1998; 42: 2–7.
   Google Scholar
• Elmer G, Surawiz C, McFarland L. Biotherapeutic agents: a neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 1996; 275: 870–7.
   Google Scholar